Prestige Consumer Healthcare Inc (PBH)
70.12
-0.02
(-0.03%)
USD |
NYSE |
Apr 26, 14:06
Prestige Consumer Healthcare Price to Book Value: 2.175 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 2.176 |
April 24, 2024 | 2.175 |
April 23, 2024 | 2.209 |
April 22, 2024 | 2.165 |
April 19, 2024 | 2.161 |
April 18, 2024 | 2.120 |
April 17, 2024 | 2.110 |
April 16, 2024 | 2.111 |
April 15, 2024 | 2.114 |
April 12, 2024 | 2.116 |
April 11, 2024 | 2.146 |
April 10, 2024 | 2.138 |
April 09, 2024 | 2.146 |
April 08, 2024 | 2.129 |
April 05, 2024 | 2.145 |
April 04, 2024 | 2.165 |
April 03, 2024 | 2.154 |
April 02, 2024 | 2.170 |
April 01, 2024 | 2.224 |
March 28, 2024 | 2.251 |
March 27, 2024 | 2.253 |
March 26, 2024 | 2.233 |
March 25, 2024 | 2.221 |
March 22, 2024 | 2.272 |
March 21, 2024 | 2.292 |
Date | Value |
---|---|
March 20, 2024 | 2.276 |
March 19, 2024 | 2.282 |
March 18, 2024 | 2.284 |
March 15, 2024 | 2.316 |
March 14, 2024 | 2.296 |
March 13, 2024 | 2.329 |
March 12, 2024 | 2.300 |
March 11, 2024 | 2.313 |
March 08, 2024 | 2.286 |
March 07, 2024 | 2.252 |
March 06, 2024 | 2.215 |
March 05, 2024 | 2.210 |
March 04, 2024 | 2.233 |
March 01, 2024 | 2.175 |
February 29, 2024 | 2.158 |
February 28, 2024 | 2.158 |
February 27, 2024 | 2.167 |
February 26, 2024 | 2.171 |
February 23, 2024 | 2.163 |
February 22, 2024 | 2.153 |
February 21, 2024 | 2.149 |
February 20, 2024 | 2.133 |
February 16, 2024 | 2.145 |
February 15, 2024 | 2.134 |
February 14, 2024 | 2.10 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.282
Minimum
Mar 23 2020
2.329
Maximum
Mar 13 2024
1.776
Average
1.796
Median
Feb 03 2023
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 1.834 |
Palatin Technologies Inc | -- |
iBio Inc | 0.6592 |
Theriva Biologics Inc | 0.1946 |
Oragenics Inc | 2.929 |
Price to Book Value Related Metrics
PS Ratio | 3.094 |
Price to Free Cash Flow | 15.12 |
Price | 70.12 |
Earnings Yield | -2.34% |
Market Cap | 3.481B |
Operating PE Ratio | 10.04 |